(Q95793697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

review article

1 reference

title

Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

main subject

Staphylococcus aureus

1 reference

methicillin-resistant Staphylococcus aureus

inferred from title

1 reference

1 reference

I Eltringham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

Journal of Hospital Infection

30 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent

30 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: value of topical mupirocin and of traditional methods of infection control

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Pseudomonic Acid: an Antibiotic produced by Pseudomonas fluorescens

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Structure of pseudomonic acid, an antibiotic from Pseudomonas fluorescens

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

The antimicrobial activity of mupirocin—an update on resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Prevalence of mupirocin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin resistance in methicillin-resistant Staphylococcus aureus from a veterans hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin resistance in staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

1 reference

7 January 2021

High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin resistance in coagulase-negative staphylococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Detection and characterization of mupirocin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Probes for the study of mupirocin resistance in staphylococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Mupirocin-resistant MRSA.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16)

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium. Fermentation, isolation, structure, and antimicrobial activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

An Outbreak of Infections Caused by Strains of Staphylococcus aureus Resistant to Methicillin and Aminoglycosides. I. Clinical Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

The carrier state: methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2897%2990162-6

7 January 2021

10.1016/S0195-6701(97)90162-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9032630%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference